The Benefit-Risk Dialogue: A Deep Dive into Efficacy and Safety Data of a JAK Inhibitor

Speaker(s)

• 

  Anita Afzali, MD, MPH, MHCM, FACG, AGAF

  Professor of Medicine; Executive Vice Chair of Internal Medicine; Associate Chief Medical Officer of UC Health and Cincinnati Children's Hospital
  University of Cincinnati
  Cincinnati, Ohio